2 Top Marijuana Stocks For Investors To Focus OnThe evolution of the cannabis industry, starting from 2018, is nothing short of amazing. Even the ideas on all the positive outcomes that could happen, no one knew that legal cannabis would be this explosive. With more than half of the USA and various places around the globe, in 2025, the legal cannabis market has been shown to be just as legitimate and profitable as other industries.From what was once taboo and shared privately, legal cannabis is here to stay ...

Key Points Warren Buffett buys good businesses when they are attractively priced and then holds for the long term. If you are a dividend investor, you need to think like Buffett, with a focus on reliable dividend stocks. There's an easy way for dividend lovers to hone their search and find just the right picks for them. 10 stocks we like better than United Parcel Service › Warren Buffett, the world famous CEO of Berkshire Hathaway, is not a dividend investor, per se, but his general approach is o ...

财务业绩 - 第三季度调整后收益为81亿美元，每股收益1.88美元，超出华尔街预期的每股1.82美元，较第二季度的71亿美元有所增长 [1] - 上游业务利润达到57亿美元，高于第二季度的54亿美元，炼油业务贡献18亿美元 [4] - 自由现金流降至63亿美元，低于一年前的113亿美元，主要原因是公司在二叠纪盆地收购土地支出增加 [2] 运营表现 - 油气产量增至480万桶油当量/日，高于第二季度的460万桶油当量/日，圭亚那和二叠纪盆地产量创下纪录 [2] - 尽管布伦特原油平均价格同比下跌13%至68.17美元，但创纪录的产量帮助抵消了价格疲软的影响 [2] - 公司记录了5.1亿美元的重组成本 [3] 资本配置与战略 - 季度股息提高4%至每股1.03美元，并确认有望在今年完成200亿美元的股票回购计划 [3] - 上一季度向股东返还93亿美元 [3] - 全年资本支出预计将略低于270亿至290亿美元的指导范围 [3] - 公司继续专注于长期投资，以扩大产能应对未来需求增长 [4] 重点项目进展 - 随着安全条件改善，公司正“处于”解除莫桑比克300亿美元Rovuma液化天然气项目不可抗力的过程中 [5] - 此举紧随道达尔能源重启其邻近项目的决定，可能为莫桑比克到2040年成为全球前十大天然气生产国铺平道路 [5] - 公司强调在圭亚那、二叠纪盆地和液化天然气领域资助增长的同时，保持资本纪律和股东回报 [6]

My previous investment thought on Xylem Inc. ( XYL ) was a buy rating because of the strong secular tailwinds that it benefits from. Also, the Evoqua integration and PFAS funding pipeline couldI focus on long-term investments while incorporating short-term shorts to uncover alpha opportunities. My investment approach revolves around bottom-up analysis, delving into the fundamental strengths and weaknesses of individual companies. My investment duration is the medium to long-term. Ultimately, I aim to identi ...

My previous investment thought on Xylem Inc. ( XYL ) was a buy rating because of the strong secular tailwinds that it benefits from. Also, the Evoqua integration and PFAS funding pipeline couldI focus on long-term investments while incorporating short-term shorts to uncover alpha opportunities. My investment approach revolves around bottom-up analysis, delving into the fundamental strengths and weaknesses of individual companies. My investment duration is the medium to long-term. Ultimately, I aim to identi ...

公司概况与市场地位 - 诺华公司是一家总部位于瑞士的全球医疗保健公司 以创新药物和治疗方案闻名 业务涵盖制药和肿瘤学等多个领域 [1] - 公司是医疗保健行业的重要参与者 市场估值约为2411.4亿美元 显示出强大的市场地位 [4] - 公司与辉瑞和罗氏等其他主要制药公司存在竞争关系 [1] 投资评级与观点 - CFRA维持对诺华公司的"持有"评级 目标股价设定为126美元 表明对其股价稳定性的预期 [1][5] - Zacks投资研究将诺华公司列为长期投资的首选价值股 认为其有潜力超越市场表现 [2][5] 股价表现与交易数据 - 当前股价为123.59美元 较前一日上涨0.16美元 涨幅为0.13% 当日交易区间在121.65美元至123.91美元之间 [3] - 过去52周内 股价最高达到133.55美元 最低为96.06美元 显示出一定的波动性但也蕴含增长潜力 [3] - 股票交易活跃 成交量为1,377,675股 反映出持续的投资兴趣 [4]

I ventured into investing in high school in 2011, mainly in REITs, preferred stocks, and high-yield bonds, starting a fascination with markets and the economy that has not faded despite the years. More recently I have been combining long stock positions with covered calls and cash secured puts. I approach investing purely from a fundamental long-term point of view. On Seeking Alpha I mostly cover REITs and financials, with occasional articles on ETFs and other stocks driven by a macro trade idea.Analyst’s D ...

I ventured into investing in high school in 2011, mainly in REITs, preferred stocks, and high-yield bonds, starting a fascination with markets and the economy that has not faded despite the years. More recently I have been combining long stock positions with covered calls and cash secured puts. I approach investing purely from a fundamental long-term point of view. On Seeking Alpha I mostly cover REITs and financials, with occasional articles on ETFs and other stocks driven by a macro trade idea.Analyst’s D ...

The Oracle of Omaha has long contended that in the long run, simpler, less active portfolios perform better.If 2025 is the year you're first getting into the market, you've picked a wild one to get started. A small number of massive technology companies have soared thanks to their involvement with artificial intelligence (AI), dragging the overall market higher with them.This kind of mania isn't the norm though. And it will unwind sooner or later, deflating most portfolio values when it does.Not every stock ...

I've been in the investing world for almost 10 years now, in which time I've garnered a lot of experience around what works and what doesn't. Over this period, one lesson that has impressed itself upon me is that you should really be looking for investment opportunities that "hit you like a 2x4-to-the-head with how obvious they are," to paraphrase Mohnish Pabrai. As a result of this, in my writing on Seeking Alpha, my goal is to be able to communicate ideas simply, as the investing game is already difficult ...